Precision Business Insights has published a report on the global heparin market, estimating its value at USD 7.8 Billion in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 2.7% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/heparin-market

Market Definition:

One naturally occurring anticoagulant that keeps blood from clotting is heparin. It is a member of a group of substances called glycosaminoglycans, which are big, intricate molecules composed of negatively charged, highly sulfated repeating sugar units.

Drivers:

1) Rising incidence of cardiovascular diseases.
2) Increase in use of low molecular weight heparins.

The global heparin market segmentation:

1) By Product: Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), Ultra-low Molecular Weight Heparin (ULMWH.
2) By Application: Venous Thromboembolism, Coronary Artery Disease, Atrial Fibrillation, Others.
3) By Distribution Channel: Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies.

Regional Overview:
The report also examines the current concerns and their Future Effects on the heparin market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the heparin market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.

·         North America (U.S., Canada)

·         Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)

·         Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)

·         Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)

·         Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

The competitive landscape is dominated by major players like Pfizer Inc. | Sanofi S.A. | LEO Pharma A/S | Dr. Reddy’s Laboratories Ltd. | GlaxoSmithKline plc (GSK) | Aspen Holdings | Fresenius SE & Co. KGaA | B. Braun Medical Inc. | Baxter International Inc. | Bioiberica S.A.U. | Hebei Changshan Biochemical Pharmaceutical Co., Ltd. | Teva Pharmaceutical Industries Ltd. | Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. | Changzhou Qianhong Biopharma Co., Ltd. | Laboratorios Farmacéuticos ROVI S.A. | Shenzhen Hepalink Pharmaceutical Group Co., Ltd. | Yantai Dongcheng Biochemicals Co., Ltd. | Opocrin S.p.A. | Sandoz (Novartis AG) | Amphastar Pharmaceuticals Inc. | McKesson Corporation | AmerisourceBergen Corporation | Cardinal Health Inc. | Sun Pharmaceutical Industries Ltd. | Cipla Ltd. | Intas Pharmaceuticals Ltd. | Glenmark Pharmaceuticals Ltd. | Mylan N.V. | Hikma Pharmaceuticals plc | Wockhardt Ltd. | Lupin Limited | Aurobindo Pharma Ltd. | Fresenius Kabi AG | Jubilant Life Sciences Ltd. | Pharmstandard JSC | Sinopharm Group Co., Ltd. | Zhejiang Huahai Pharmaceutical Co., Ltd. | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | Daiichi Sankyo Company Ltd. | Teijin Pharma Ltd. | UCB S.A. | Merck KGaA | Novartis AG | Johnson & Johnson | AbbVie Inc. | AstraZeneca plc | Bayer AG | Roche Holding AG | Eli Lilly and Company | Bristol-Myers Squibb Company

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747